Showing results (1231-1240 of 1,512) with videos related to

Sort By:
Pageof 152
Cancer Immunology, Immunotherapy : CII|January 3, 2021
Discovery of acquired molecular signature on immune checkpoint inhibitors in paired tumor tissuesShin Hye Yoo, Jihui Yun, Bhumsuk Keam, et al.
Thoracic Cancer|January 18, 2021
Tumor LAG-3 and NY-ESO-1 expression predict durable clinical benefits of immune checkpoint inhibitors in advanced non-small cell lung cancerEun Hee Jung, Hee Ryeong Jang, Se Hyun Kim, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 11, 2022
Association of coronary artery calcium with adverse cardiovascular outcomes and death in patients with chronic kidney disease: results from the KNOW-CKDChan-Young Jung, Hae-Ryong Yun, Jung Tak Park, et al.
British Journal of Cancer|October 5, 2020
A Phase 1 study of gefitinib combined with durvalumab in EGFR TKI-naive patients with EGFR mutation-positive locally advanced/metastatic non-small-cell lung cancerBenjamin C Creelan, Tammie C Yeh, Sang-We Kim, et al.
JTO Clinical and Research Reports|January 13, 2022
Clinical Characteristics and Outcomes in Advanced KRAS-Mutated NSCLC: A Multicenter Collaboration in Asia (ATORG-005)Jiyun Lee, Aaron C Tan, Siqin Zhou, et al.
Scientific Reports|March 24, 2021
Low-dose aspirin was associated with an increased risk of cardiovascular events in patients with chronic kidney disease patients and low bodyweight: results from KNOW-CKD studyYun Jung Oh, Ae Jin Kim, Han Ro, et al.
The American Journal of Gastroenterology|July 3, 2018
EUS-Guided Biliary Drainage Versus ERCP for the Primary Palliation of Malignant Biliary Obstruction: A Multicenter Randomized Clinical TrialWoo Hyun Paik, Tae Hoon Lee, Do Hyun Park, et al.
Plos One|July 11, 2013
Lumican Accelerates Wound Healing by Enhancing α2β1 Integrin-Mediated Fibroblast ContractilityXiao-Jin Liu, Fan-Zhi Kong, Ya-Hui Wang, et al.
Lung Cancer (Amsterdam, Netherlands)|December 3, 2014
Additional prognostic role of EGFR activating mutations in lung adenocarcinoma patients with brain metastasis: integrating with lung specific GPA scoreDae-Won Lee, Dong-Yeop Shin, Jin Wook Kim, et al.
Lung Cancer (Amsterdam, Netherlands)|February 23, 2016
A multicenter phase II study of sorafenib in combination with erlotinib in patients with advanced non-small cell lung cancer (KCSG-0806)Sun Min Lim, Byoung Chul Cho, Sang-We Kim, et al.
Pageof 152